Frontier Medicines

Frontier Medicines

Edit info

  • Founded: 2018
  • Location: South SF, CA
  • Employee range: 11 - 50
  • Clinical stage: Clin0
  • Therapy area: Oncology
  • Drug types: ONC
  • Lead product: FMC-376
  • Funding: $88.5M B Jul 2021; $67M A Jun 2019
  • Investors: Deerfield Management, Droia Oncology Ventures, MPM Capital


frontiermeds.com

linkedin.com

job board


Business:

Drug Discovery Using Chemoproteomics Platform

Drug notes:

7 additional undisclosed programs RD oncology

About:

Frontier Medicines is generating medicines to treat previously undruggable disease-causing targets. Chemoproteomics is an approach to understand the interaction between small molecules and proteins in cellular contexts. Frontier is using their proprietary platform, powered by chemoproteomics along with covalent chemistry and machine learning to accelerate the discovery and development of precision medicines. The platform uses insights from proteome screening in disease relevant systems along with proprietary techniques and algorithms enabling rapid identification and assessment of actionable leads for undruggable targets. Frontier is using their platform to build a pipeline of precision medicines initially focused on oncology.

Frontier Medicines
Sr./Executive Director, Preclinical Development Te...
Boston, MA|44 days ago
Apply
Frontier Medicines
Associate Director, Clinical Operations
South San Francisco, CA|44 days ago
Frontier Medicines
Director/Sr. Director, Head of Process Chemistry
South San Francisco, CA|44 days ago
Frontier Medicines
Director/Sr. Director, Head of Process Chemistry
Boston, MA|51 days ago


© 2025 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com